Recombinant Human Fumarylacetoacetase is produced by our Mammalian expression system and the target gene encoding Ser2-Ser419 is expressed with a 6His tag at the C-terminus. Bon Opus Cat. #C874

Recombinant Human Fumarylacetoacetase/FAH (C-6His)

Name: Recombinant Human Fumarylacetoacetase/FAH (C-6His)
SKU: C874-10ug

SKU: C874-10ug

$158.00

Quantity

[{"key":"C874-500ug","value":"Backorder"},{"key":"C874-50ug","value":"Backorder"},{"key":"C874-1mg","value":"Backorder"},{"key":"C874-10ug","value":"In Stock"}]

FAQ

Contact Us

Phone: 800-943-6396 ext#1

Email: orders@bonopusbio.com

Distributors

Have Other Questions?

Shipping Information

$48 Standard Overnight flat rate for products shipped in room temperature within the United States.

Additional $27 Ice Packs shipment fee is required for liquid proteins.

Please contact us to order for international shipments.

Certificate of Analysis

Datasheet not available? Submit a request here

Endotoxin

Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.

Accession Number

P16930

Species

Human

Expression System

Human Cells

Target Sequence

Ser2-Ser419

C-His

Formulation

Lyophilized from a 0.2 um filtered solution of 20mM Tris-HCl,150mM NaCl,pH8.5.

Packaging

Ambient

Background

Fumarylacetoacetase belongs to the FAH family. Fumarylacetoacetase is primary expressed in liver and kidney. It exists as a homodimer and catalyzes the hydrolysis of 4-fumarylacetoacetate into fumarate and acetoacetate. Defects in Fumarylacetoacetase cause tyrosinemia type 1, which is congenital metabolism defect characterized by elevated levels of tyrosine in the blood and urine, and hepatorenal manifestations. Typical features include renal tubular injury, self-mutilation, hepatic necrosis, episodic weakness, and seizures.